AdaptHealth Corp

AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. It focuses on sleep therapy equipment to individuals suffering from obstructive sleep apnea (OSA), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs. The company was founded in 2012 and is headquartered in Plymouth Meeting, PA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

AdaptHealth Corp reports robust revenue growth and strategic investments outlook

AdaptHealth Corp demonstrated resilience in revenue growth despite challenges, with a strong focus on patient care and financial performance. While facing short-term obstacles, the company is strategically positioned to capitalize on growth opportunities and improve margins through cost-cutting measures.

AdaptHealth Corp reports revenue growth amidst diabetes business challenges

AdaptHealth Corp's Q1 2023 performance showed revenue growth but faced challenges in the diabetes business, prompting cost-saving measures.
Despite hurdles, the company remains confident in its strategy, focusing on growth opportunities and operational efficiency to drive performance.
Management's proactive approach to cost reduction and revenue enhancement positions AdaptHealth well for future growth and financial stability.

AdaptHealth Corp posts solid Q2 results, eyes growth opportunities

AdaptHealth Corp's Q2 performance reflects strong revenue growth and improved EBITDA, driven by key product lines.
While challenges exist in the diabetes segment, the company is focused on operational enhancements and cost-saving measures.
Opportunities for growth and efficiency improvements are present, with a commitment to executing strategies and leveraging expertise.
Management's emphasis on financial processes and operational efficiency bodes well for future performance and market positioning.

AdaptHealth Corp reports record revenues, faces EBITDA challenges, eyes growth

AdaptHealth Corp's Q3 performance reflects revenue growth driven by the sleep business, with a focus on enhancing patient experience. Challenges include EBITDA shortfall due to contract delays and impairment to goodwill. The company is seizing opportunities in CGM data utilization and diversification strategies for growth.
With a strong emphasis on patient care and operational efficiency, AdaptHealth Corp is navigating challenges in revenue decline and tough comps, aiming for sustained growth. The company's strategic focus on market penetration and patient outcomes positions them for future success.

AdaptHealth Corp excels in Q4 2023, eyes growth opportunities

AdaptHealth Corp's strong performance in Q4 2023 and full-year highlights organic growth.
Challenges from GLP-1 drugs and government exposure are being addressed proactively.
Opportunities lie in projected revenue growth, market share improvement, and cost reduction.
Overall, AdaptHealth is well-positioned for continued growth and market resilience.

AdaptHealth Corp excels in Q1 2024, eyes growth and debt reduction

AdaptHealth Corp's Q1 2024 performance reflects solid financial growth, operational improvements, and strategic initiatives aimed at enhancing profitability and market position.
While challenges like managing potential risks in key segments and addressing debt obligations exist, the company's strengths in leadership, revenue diversification, and cost management provide a strong foundation for future success.
By capitalizing on growth opportunities in key business segments and markets, AdaptHealth Corp is well-positioned to achieve its financial targets, drive sustainable growth, and enhance shareholder value.

AdaptHealth Corp reports solid Q2 results and raises full-year guidance

AdaptHealth Corp's Q2 performance met expectations with a strong focus on driving growth through investments and operational improvements. Despite challenges in certain revenue segments, the company remains optimistic about future prospects.

AdaptHealth Corp reports solid Q3 performance amid operational enhancements

AdaptHealth Corp's Q3 results reflect resilience and strategic initiatives to drive growth amidst operational challenges.
The company's proactive measures to address issues in the diabetes segment and optimize other product lines position it for future success.
With a strengthened financial position and a focus on operational efficiency, AdaptHealth is poised for sustainable growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp.

AdaptHealth Corp. Schedules Second Quarter 2020 Financial Results and Conference Call

American Water Works

Kinross Gold

Procter & Gamble

PulteGroup

We have selected five stocks that are positioned to gain from the Fed's holding of interest rates at an all-time low.

5 Stocks to Add as Fed Keeps Rates Unchanged

AdaptHealth Corp. Appoints David S.

AdaptHealth Announces Pricing of Upsized $350.0 Million Senior Notes Due 2028

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a leading provider of home medical equipment, supplies and related services in the United States, announced today that its subsidiary, AdaptHealth LLC (the “Issuer”), has commenced, subject to market and other conditions, an offering of $300.0 million aggregate principal amount of senior notes due 2028 (the “senior notes”). It is expected that the senior notes will be guaranteed by certain

AdaptHealth Announces Proposed Offering of $300.0 Million Senior Notes Due 2028

As of late, it has definitely been a great time to be an investor in AdaptHealth.

AdaptHealth's Shares March Higher, Can It Continue?

AdaptHealth (AHCO) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.

AdaptHealth (AHCO) Catches Eye: Stock Jumps 6.5%

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a leading provider of home medical equipment, supplies and related services in the United States, announced today that it has closed the previously announced acquisitions of Solara Medical Supplies, LLC (“Solara”) and ActivStyle, Inc. (“ActivStyle”). The acquisitions were consummated for combined total consideration of approximately $487 million consisting of approximately $424.5 million i

AdaptHealth Closes Previously Announced Acquisitions of Solara Medical Supplies and ActivStyle

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a leading provider of home medical equipment, supplies and related services in the United States, announced today the upsizing and pricing of its previously announced underwritten public offering of 8,000,000 shares of its Class A Common Stock at a price to the public of $15.50 per share. The size of the offering was increased from the previously announced 6,500,000 shares of common stock.

AdaptHealth Corp. Announces Pricing of Upsized Public Offering of Class A Common Stock

Aravive Inc

Cancer Genetics

Genius Brands

Sunnova Energy International Inc

PaySign Inc

RumbleON

Investors have had a love affair with the market around underwritten initial public offerings for many years, but the other side of the underwriting world revolves around secondary offerings and capital raises.

Secondary Offerings and Capital Raises Weigh Heavily on 7 Stocks

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Is DFB Healthcare Acquisitions Corp. (AHCO) Stock Undervalued Right Now?

DFB Healthcare Acquisitions Corp. (AHCO) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects.

DFB Healthcare Acquisitions Corp. (AHCO) Upgraded to Strong Buy: Here's What You Should Know

Are Investors Undervaluing DFB Healthcare Acquisitions Corp. (AHCO) Right Now?

F&G Annuities & Life Inc

Picking breakout stocks is one of the most favored methods for people utilizing an active investing approach as this strategy offers scope for superlative returns.

Pick These 3 Breakout Stocks for Explosive Returns

DFB Healthcare Acquisitions Corp. (AHCO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Can DFB Healthcare Acquisitions Corp. (AHCO) Run Higher on Rising Earnings Estimates?

National Vision Hlds

EYE vs. AHCO: Which Stock Is the Better Value Option?

EYE vs. AHCO: Which Stock Should Value Investors Buy Now?

News for AdaptHealth Corp Stock (AHCO)